Other

Conde-Knape makes the future of pharmaceuticals possible at Novo Nordisk

The world has been her playground, and now, Karin Conde-Knape is using her international experiences as the woman in charge of Global Drug Discovery at Novo Nordisk.
BY FREDERIK TILLITZ, TRANSLATED BY CATHERINE BRETT AND DANIEL PEDERSEN

Karin Conde-Knape became the senior vice president of global drug discovery at Novo Nordisk a little over a year ago. Here, she's in charge of preliminary research withinin several therapy areas that are of interest to the pharmaceutical giant.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
    • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Related articles

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading

    Jobs